BWX Technologies (NYSE:BWXT) Posts Earnings Results

BWX Technologies (NYSE:BWXT) released its quarterly earnings data on Monday. The technology company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.04 by $0.03, FiscalAI reports. The firm had revenue of $901.62 million for the quarter, compared to analyst estimates of $902.80 million. BWX Technologies had a net margin of 10.20% and a return on equity of 31.33%. The business’s quarterly revenue was up 18.0% compared to the same quarter last year. During the same period last year, the firm earned $1.02 earnings per share. BWX Technologies updated its FY 2026 guidance to 4.700-4.800 EPS.

Here are the key takeaways from BWX Technologies’ conference call:

• Strong quarterly results and raised guidance: Second-quarter revenue rose 18%, adjusted EBITDA increased 7%, and adjusted EPS grew 5%. BWXT raised its 2026 adjusted EBITDA guidance to $662 million–$672 million, EPS guidance to $4.70–$4.80, and free cash flow guidance to $345 million–$360 million.
• Robust demand and backlog growth: Backlog reached $8.4 billion, up 40% year over year, with a trailing-12-month book-to-bill ratio of 1.7x. Management said it expects a credible opportunity to secure at least one new-build nuclear equipment order before year-end.
• Portfolio simplification and strategic focus: BWXT agreed to sell more than 80% of its medical and stable-isotope enrichment businesses to Nordic Capital for $750 million upfront and up to $800 million, while retaining a 20% minority stake. The transaction is intended to focus capital and management resources on national security and commercial nuclear power.
• Commercial nuclear capacity investments will weigh on near-term margins: Commercial Operations revenue grew 72% and adjusted EBITDA more than doubled, but 2026 segment margin guidance was reduced to approximately 13% from 14% as BWXT invests in U.S. capacity, PCG integration, Canadian operations, and additional executive talent.
• Long-term growth opportunities are expanding: The company cited support from U.S. and Canadian nuclear initiatives, a more consistent U.S. aircraft-carrier procurement cadence, advanced nuclear fuel milestones, and potential mPower licensing and manufacturing agreements. BWXT also expects to decide soon on a deep-water U.S. commercial manufacturing site to produce large reactor components.

BWX Technologies Price Performance

BWX Technologies stock opened at $174.64 on Tuesday. BWX Technologies has a 52 week low of $149.57 and a 52 week high of $241.82. The company’s 50 day moving average price is $187.47 and its two-hundred day moving average price is $201.53. The stock has a market cap of $16.00 billion, a P/E ratio of 46.70, a P/E/G ratio of 2.87 and a beta of 0.76. The company has a quick ratio of 2.33, a current ratio of 2.40 and a debt-to-equity ratio of 1.58.

BWX Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 4th. Shareholders of record on Tuesday, August 18th will be given a dividend of $0.27 per share. The ex-dividend date of this dividend is Tuesday, August 18th. This represents a $1.08 annualized dividend and a dividend yield of 0.6%. BWX Technologies’s dividend payout ratio (DPR) is currently 28.88%.

Insider Buying and Selling

In other BWX Technologies news, CEO Rex D. Geveden sold 10,000 shares of the company’s stock in a transaction on Tuesday, May 12th. The stock was sold at an average price of $204.81, for a total value of $2,048,100.00. Following the completion of the transaction, the chief executive officer owned 202,491 shares in the company, valued at $41,472,181.71. This represents a 4.71% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Michael Thomas Fitzgerald sold 2,417 shares of BWX Technologies stock in a transaction on Monday, May 11th. The stock was sold at an average price of $209.25, for a total value of $505,757.25. Following the sale, the chief financial officer owned 6,884 shares in the company, valued at $1,440,477. The trade was a 25.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 0.60% of the company’s stock.

Institutional Trading of BWX Technologies

A number of large investors have recently added to or reduced their stakes in BWXT. WFA of San Diego LLC bought a new position in shares of BWX Technologies during the 2nd quarter valued at approximately $29,000. Ancora Advisors LLC bought a new stake in shares of BWX Technologies in the 3rd quarter worth approximately $49,000. Quarry LP lifted its stake in BWX Technologies by 158.3% in the fourth quarter. Quarry LP now owns 359 shares of the technology company’s stock valued at $62,000 after purchasing an additional 220 shares during the last quarter. Greenline Wealth Management LLC purchased a new position in BWX Technologies in the fourth quarter valued at approximately $69,000. Finally, Rakuten Securities Inc. grew its holdings in BWX Technologies by 309.7% during the second quarter. Rakuten Securities Inc. now owns 463 shares of the technology company’s stock valued at $67,000 after purchasing an additional 350 shares during the period. Hedge funds and other institutional investors own 94.39% of the company’s stock.

Key Headlines Impacting BWX Technologies

Here are the key news stories impacting BWX Technologies this week:

• Positive Sentiment: BWXT reported second-quarter adjusted earnings of $1.07 per share, exceeding the $1.04 analyst consensus and rising from $1.02 a year earlier. Revenue increased 18% year over year to approximately $901.6 million, while management cited strong execution, commercial growth and solid free-cash-flow generation. BWX Technologies Reports Second Quarter 2026 Results
• Positive Sentiment: The company maintained or updated fiscal 2026 EPS guidance to $4.70–$4.80, above the roughly $4.69 consensus estimate. Revenue guidance of about $3.8 billion was in line with expectations, reducing the risk of a near-term outlook cut.
• Positive Sentiment: BWXT agreed to sell BWXT Medical and Kinectrics’ stable medical-isotopes business to Nordic Capital in a transaction valued at up to $800 million. The deal should provide capital for the company’s core nuclear and defense operations, while BWXT will retain a minority interest in the new company. BWXT Selling Medical Business to Nordic Capital
• Neutral Sentiment: BWXT declared a quarterly dividend of $0.27 per share, or $1.08 annualized, representing a yield of approximately 0.6%. Investors on record August 18 will receive payment September 4; the ex-dividend date is August 18.
• Negative Sentiment: Quarterly revenue of approximately $901.6 million was modestly below the $902.8 million consensus estimate. In addition, selling the medical business may reduce near-term revenue diversification, even though the transaction supports BWXT’s strategic focus and balance-sheet flexibility.

Wall Street Analyst Weigh In

BWXT has been the topic of a number of analyst reports. Truist Financial upped their target price on shares of BWX Technologies from $205.00 to $212.00 and gave the stock a “hold” rating in a report on Monday, May 11th. Zacks Research downgraded BWX Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft raised BWX Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $205.00 to $255.00 in a report on Friday, May 15th. Seaport Research Partners raised BWX Technologies from a “neutral” rating to a “buy” rating and set a $245.00 price objective for the company in a research note on Monday, June 22nd. Finally, JPMorgan Chase & Co. began coverage on BWX Technologies in a report on Monday, July 27th. They issued an “overweight” rating and a $230.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, BWX Technologies has an average rating of “Moderate Buy” and a consensus price target of $228.20.

About BWX Technologies

BWX Technologies, Inc (NYSE: BWXT) is a specialized supplier of nuclear components and services, primarily serving the U.S. government and commercial markets. The company’s core expertise lies in the design, fabrication and servicing of nuclear propulsion systems for the U.S. Navy, where it supports the maintenance and overhaul of naval nuclear reactors. In addition to defense applications, BWXT develops small modular reactors (SMRs), nuclear fuel and related technologies for non‐defense power generation, offering scalable solutions to meet evolving energy and industrial demands.

Beyond propulsion and power systems, BWXT is a leading producer of medical radioisotopes used in diagnostic imaging and cancer treatment.